BridgeBio Pharma BBIO
NASDAQ BBIO
$80.31 +0.77 (+0.97%)
As of: Nov 12, 2026 · 11:48 AM EST

BridgeBio Pharma (BBIO) Return on Invested Capital [ROIC] (2026)

Updated

BridgeBio Pharma (BBIO) posted Return on Invested Capital [ROIC] of -92.63% for Q3 2026, up 472.24 percentage points from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Return on Invested Capital [ROIC] (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 BridgeBio Pharma 15.42 Bn 11.64 Bn 332.72 Mn -92.63%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -92.63%
Jun 30, 2026 -564.87%
API Access

BridgeBio Pharma Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=BBIO&period=max&api_key=YOUR_API_KEY